v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flow from operating activities:    
Net income (loss) $ 874 $ (19,754)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operations:    
Depreciation and amortization 1,597 1,834
Non cash lease expense 20 32
Provision for inventory obsolescence (123)
Provision for credit losses 200 (61)
Change in fair value of warrant liabilities 87 (242)
Issuance of warrants due to Strategic Advisory Agreement 256
Loss on issuance of common stock to Yorkville in connection with the Side Letter 149
Loss on issuance of common stock in connection with the settlement of debt 300 51
Share-based compensation expense 1,243 2,637
Director fees paid with RSU’s 128
Loss on extinguishment of debt 5,736
Change in fair value of debt 166 12
Non cash interest expense 166 2,451
Changes in operating assets and liabilities:    
Accounts receivable (328) (1,350)
Inventory 215 2,550
Prepaid expenses and other assets 251 251
Accounts payable (1,322) 17
Accrued expenses and other liabilities (1,675) 2,709
Lease liabilities 77 83
Deferred revenue (808) 25
Net cash provided by (used in) operating activities 1,447 (2,993)
Cash flow from financing activities:    
Issuance of common stock to Dragasac as consideration for inducement agreement 2,460
Repayments of short-term debt - unaffiliated (7,042)
Payment of SEPA commitment fee (300)
Repayments of other short-term debt - related party (R. Hariri) (42)
Tax withholding on vesting of restricted stock units (98)
Net cash (used in) provided by financing activities (7,342) 2,320
Net decrease in cash, cash equivalents and restricted cash (5,895) (673)
Cash, cash equivalents and restricted cash at beginning of period 16,372 10,977
Cash, cash equivalents and restricted cash at end of period 10,477 10,304
Supplemental non-cash investing and financing activities:    
Contingent consideration accrued in connection with Rebound asset acquisition 650
Deemed dividend relating to inducement of Dragasac warrants $ 64